Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?

Covid-19 infection caused by the novel coronavirus SARS-COV-2 continues to be a major global health challenge. Till date, no drug has been approved for the treatment of this infection. A number of medications have been proposed and there are ongoing clinical trials around the world to find a suitabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Owa, Adewale Bayode, Owa, Olufunke Tolulope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247474/
https://www.ncbi.nlm.nih.gov/pubmed/32474026
http://dx.doi.org/10.1016/j.jmii.2020.05.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247474/
https://www.ncbi.nlm.nih.gov/pubmed/32474026
http://dx.doi.org/10.1016/j.jmii.2020.05.014

Ejemplares similares